RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Tron Pharmaceuticals Stock

Tron Pharmaceuticals EBIT 2024

Tron Pharmaceuticals EBIT

-1.23 M USD

Ticker

TGRP

ISIN

US8970121005

WKN

A2QL98

In 2024, Tron Pharmaceuticals's EBIT was -1.23 M USD, a 35.16% increase from the -910,000 USD EBIT recorded in the previous year.

The Tron Pharmaceuticals EBIT history

YEAREBIT (undefined USD)
2017-
2016-

Tron Pharmaceuticals Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Tron Pharmaceuticals, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Tron Pharmaceuticals from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Tron Pharmaceuticals’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Tron Pharmaceuticals. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Tron Pharmaceuticals’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Tron Pharmaceuticals’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Tron Pharmaceuticals’s growth potential.

Tron Pharmaceuticals Revenue, EBIT and net profit per share

DateTron Pharmaceuticals RevenueTron Pharmaceuticals EBITTron Pharmaceuticals Net Income
20171.48 M undefined-1.23 M undefined-800,000 undefined
20161.48 M undefined-910,000 undefined-580,000 undefined

Tron Pharmaceuticals stock margins

The Tron Pharmaceuticals margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Tron Pharmaceuticals. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Tron Pharmaceuticals.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Tron Pharmaceuticals's sales revenue. A higher gross margin percentage indicates that the Tron Pharmaceuticals retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Tron Pharmaceuticals's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Tron Pharmaceuticals's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Tron Pharmaceuticals's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Tron Pharmaceuticals. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Tron Pharmaceuticals's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Tron Pharmaceuticals Margin History

Tron Pharmaceuticals Gross marginTron Pharmaceuticals Profit marginTron Pharmaceuticals EBIT marginTron Pharmaceuticals Profit margin
201728.38 %-83.11 %-54.05 %
201646.62 %-61.49 %-39.19 %

Tron Pharmaceuticals Aktienanalyse

What does Tron Pharmaceuticals do?

The Tron Group Inc is a leading company specializing in the development and production of innovative products in various industries. It was founded in 1992 and is headquartered in New York City, with many branches worldwide. The beginnings of Tron Group Inc are in the LED lighting industry. As a pioneer in this field, the company has developed groundbreaking products that are now used globally in entertainment, retail, public events, and many other areas. With its unique ability to recognize and implement the latest technologies on the market, the company has quickly established itself as a leading provider in the lighting industry. In addition to the lighting business, the company has expanded its activities into many other industries. Today, Tron Group Inc is a significant player in the pharmaceutical industry, biomedical research, water and wastewater treatment, waste management, medical device production, and many other fields. The business model of Tron Group Inc is based on close collaboration with customers and partners in various industries. The company works closely with other companies to develop innovative products and solutions that meet the needs of its customers and society. The company is always searching for new technologies and optimization opportunities, integrating them into its products and services to achieve maximum customer satisfaction. Tron Group Inc is divided into various divisions, each offering specific products and services. An important division is Tron LED, which still focuses on manufacturing LED lighting solutions. With its wide range of products and services, Tron LED is able to meet all of its customers' requirements, from simple garden waterfall lighting to complex data visualization at concerts and major events. Another important division of Tron Group Inc is Tron Biomedical. This division offers a variety of products and services for biomedical research, including cell counting and analysis devices, artificial insemination devices, and food analysis systems. Tron Biomedical strives to integrate the latest and most advanced technologies into its products and services to advance research in this field and achieve groundbreaking advances in medicine. In addition to these main divisions, Tron Group Inc also offers a wide range of products and services in other industries. Tron Waste and Water provide innovative solutions for water and wastewater treatment and waste management, while Tron Medical Equipment manufactures medical devices and equipment such as ultrasound systems, injection systems, and patient monitoring units. Overall, Tron Group Inc is an innovative company with a wide range of products and services, constantly searching for new technologies and solutions to best serve its customers and society. With its many years of experience and commitment to high-quality products, Tron Group Inc has established itself as a leading provider in many industries and remains a key player in the global market. Tron Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Tron Pharmaceuticals's EBIT

Tron Pharmaceuticals's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Tron Pharmaceuticals's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Tron Pharmaceuticals's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Tron Pharmaceuticals’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Tron Pharmaceuticals stock

How much did Tron Pharmaceuticals achieve in EBIT for the current year?

In the current year, Tron Pharmaceuticals has achieved an EBIT of -1.23 M USD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Tron Pharmaceuticals.

How has the EBIT of Tron Pharmaceuticals developed in recent years?

The EBIT of Tron Pharmaceuticals has increased by 35.165% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Tron Pharmaceuticals?

The EBIT of Tron Pharmaceuticals is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Tron Pharmaceuticals pay?

Over the past 12 months, Tron Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Tron Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Tron Pharmaceuticals?

The current dividend yield of Tron Pharmaceuticals is .

When does Tron Pharmaceuticals pay dividends?

Tron Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Tron Pharmaceuticals?

Tron Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Tron Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Tron Pharmaceuticals located?

Tron Pharmaceuticals is assigned to the '-' sector.

Wann musste ich die Aktien von Tron Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Tron Pharmaceuticals from 11/15/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/15/2024.

When did Tron Pharmaceuticals pay the last dividend?

The last dividend was paid out on 11/15/2024.

What was the dividend of Tron Pharmaceuticals in the year 2023?

In the year 2023, Tron Pharmaceuticals distributed 0 USD as dividends.

In which currency does Tron Pharmaceuticals pay out the dividend?

The dividends of Tron Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Tron Pharmaceuticals

Our stock analysis for Tron Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Tron Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.